Free Trial
NYSEAMERICAN:CCEL

Cryo-Cell International Q4 2025 Earnings Report

Cryo-Cell International logo
$3.99 0.00 (0.00%)
Closing price 10/2/2026 04:10 PM Eastern
Extended Trading
$3.98 -0.01 (-0.25%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cryo-Cell International EPS Results

Actual EPS
-$0.47
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cryo-Cell International Revenue Results

Actual Revenue
$7.84 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cryo-Cell International Announcement Details

Quarter
Q4 2025
Time
After Market Closes
Conference Call Date
Friday, February 27, 2026
Conference Call Time
7:00AM ET

Cryo-Cell International Earnings Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
Wall Street Analysts Are Neutral on Top Healthcare Picks
See More Cryo-Cell International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cryo-Cell International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cryo-Cell International and other key companies, straight to your email.

About Cryo-Cell International

Cryo-Cell International (NYSEAMERICAN:CCEL), Inc. is a biotechnology and healthcare services company focused on the collection, processing, testing and long-term storage of umbilical cord blood and cord tissue. The company provides families with access to private stem cell banking services intended to preserve potentially valuable biological material for future medical use.

Its services generally include coordinating the collection of cord blood and tissue at birth, transporting specimens to its processing facilities, isolating and cryopreserving stem cells, and maintaining the stored materials under controlled conditions. Cryo-Cell also offers related enrollment, storage-management and customer-support services for families that choose to bank their newborn’s cord-derived cells.

Founded in 1989, Cryo-Cell is headquartered in Oldsmar, Florida. The company serves customers in the United States and has pursued international business through partnerships and distribution or licensing relationships. Its operations are centered on private cord blood and tissue banking rather than the development or sale of pharmaceutical products.

View Cryo-Cell International Profile